PUXANO

Olieweg 95

2020 Antwerpen

BE

PUXANO

Foundation date

04/09/2020

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

PUXANO is a nanotech-fueled biotech company offering a proprietary nanotechnology platform for high-throughput structure-based protein research. Our core business focuses on: (i) epitope mapping, (ii) drug design, (iii) protein engineering and (iv) biosensor development. Our main clients are Pharma and Biotech companies seeking solutions for bottlenecks that cannot be addressed by standard technologies or CRO services. For more information, please visit our website 𝘄𝘄𝘄.𝗽𝘂𝘅𝗮𝗻𝗼.𝗰𝗼𝗺.

Upcoming events

Latest news

  • SeptiCyte® RAPID receives 510(k) clearance by US FDA

    Wednesday December 1st 2021

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    Wednesday December 1st 2021

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    Wednesday December 1st 2021